CVS HEALTH Corp — Director's Dealing 2007

Aug 9, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2007-08-07

Reporting Person: MERLO LARRY J (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-08-07	Common Stock	M	130440	$18.3477	Acquired	264707	Direct
2007-08-07	Common Stock	M	200000	$18.6563	Acquired	464707	Direct
2007-08-07	Common Stock	S	330440	$37.4626	Disposed	134267	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-07	Stock Option	$18.3477	M	130440	Disposed	2008-02-27	Common Stock (130440)	Direct
2007-08-07	Stock Option	$18.6563	M	200000	Disposed	2008-03-12	Common Stock (200000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (Restricted)	59566	Direct
Stock Unit	49110	Direct
ESOP Preference Stock	1198	Indirect
Common Stock	314797	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Phantom Stock Credits	$0		Common Stock (246)	1326	Direct
Stock Option	$12.5625	2013-01-09	Common Stock (160000)	160000	Direct
Stock Option	$14.9625	2012-01-02	Common Stock (189644)	189644	Direct
Stock Option	$17.6675	2011-01-08	Common Stock (100000)	100000	Direct
Stock Option	$19.2813	2010-01-03	Common Stock (80000)	80000	Direct
Stock Option	$22.445	2012-01-05	Common Stock (100000)	100000	Direct
Stock Option	$25	2009-03-10	Common Stock (50000)	50000	Direct
Stock Option	$30.035	2013-04-03	Common Stock (161359)	161359	Direct
Stock Option	$30.2625	2011-03-07	Common Stock (100000)	100000	Direct
Stock Option	$34.42	2014-04-02	Common Stock (136089)	136089	Direct

Footnotes

F3: Reflects stock beneficially owned pursuant to issuer's ESOP Plan.

F1: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan.

F7: Option became exercisable in three annual installments, commencing 03/12/01.

F4: Includes dividend reinvestment shares acquired during the course of the year.

F6: Option became exercisable in three annual installments, commencing 02/27/01.

F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F5: Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such timee as has been elected by the reporting person.